Multicentric Study Comparing Carcinological and Functional Results of Surgery (PROPENLAP)
Primary Purpose
Cancer of the PROSTATE
Status
Unknown status
Phase
Phase 3
Locations
France
Study Type
Interventional
Intervention
Radical retropubic prostatectomy
Radical laparoscopy prostatectomy
Sponsored by
About this trial
This is an interventional treatment trial for Cancer of the PROSTATE focused on measuring Retropubic Prostatectomy, Surgical Procedures, Laparoscopic
Eligibility Criteria
Inclusion Criteria:
- Male, old patient of less than 70 years,
- having a prostate cancer proven histologically, requiring a radical prostatectomy.
- Clinical stage T1c and rate of PSA (with 20 ng/ml).
- Osseous scintiscanning and abdomen-pelvic scanner negative.
- Patient informed of the study and its participation.
- Patient affiliated to a social security system.
Exclusion Criteria:
- Contra-indication with the surgery or the anaesthesia.
- Antecedent of prostate resection or adenomectomy.
- Antecedent of inguinal hernia treatment.
- Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
- Patient privatized of freedom.
Sites / Locations
- Groupe Hospitalier Albert Chenevier Henri MondorRecruiting
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
2
1
Arm Description
Radical laparoscopy prostatectomy
Radical retropubic prostatectomy
Outcomes
Primary Outcome Measures
laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.
Secondary Outcome Measures
Carcinological (percentage of positive surgical margins, percentage of capsular crossing).
Functional (urinary continence, sexuality, quality of life)
per and post operational morbidity
economic
Full Information
NCT ID
NCT00502723
First Posted
July 17, 2007
Last Updated
July 27, 2012
Sponsor
Assistance Publique - Hôpitaux de Paris
1. Study Identification
Unique Protocol Identification Number
NCT00502723
Brief Title
Multicentric Study Comparing Carcinological and Functional Results of Surgery
Acronym
PROPENLAP
Official Title
Prostate Cancer: Multicentric Study Comparing Carcinological and Functional Results of Surgery
Study Type
Interventional
2. Study Status
Record Verification Date
January 2008
Overall Recruitment Status
Unknown status
Study Start Date
December 2007 (undefined)
Primary Completion Date
July 2012 (Anticipated)
Study Completion Date
July 2012 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Assistance Publique - Hôpitaux de Paris
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
National multicentric prospective open study, comparing two current surgical methods: laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.
Detailed Description
The aim of this study is to show that radical prostatectomy by laparoscopic way could obtain carcinological results not lower than theses with radical retropubic surgery.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cancer of the PROSTATE
Keywords
Retropubic Prostatectomy, Surgical Procedures, Laparoscopic
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
1440 (Anticipated)
8. Arms, Groups, and Interventions
Arm Title
2
Arm Type
Active Comparator
Arm Description
Radical laparoscopy prostatectomy
Arm Title
1
Arm Type
Experimental
Arm Description
Radical retropubic prostatectomy
Intervention Type
Procedure
Intervention Name(s)
Radical retropubic prostatectomy
Intervention Description
Radical retropubic prostatectomy
Intervention Type
Procedure
Intervention Name(s)
Radical laparoscopy prostatectomy
Intervention Description
Radical laparoscopy prostatectomy
Primary Outcome Measure Information:
Title
laparoscopic way versus open retropubic way among patients requiring a radical prostatectomy for a localised prostate cancer.
Time Frame
during the study
Secondary Outcome Measure Information:
Title
Carcinological (percentage of positive surgical margins, percentage of capsular crossing).
Time Frame
after the surgical
Title
Functional (urinary continence, sexuality, quality of life)
Time Frame
at 2 years
Title
per and post operational morbidity
Time Frame
during the 36 months
Title
economic
Time Frame
duration and cost of hospitalization
10. Eligibility
Sex
Male
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Male, old patient of less than 70 years,
having a prostate cancer proven histologically, requiring a radical prostatectomy.
Clinical stage T1c and rate of PSA (with 20 ng/ml).
Osseous scintiscanning and abdomen-pelvic scanner negative.
Patient informed of the study and its participation.
Patient affiliated to a social security system.
Exclusion Criteria:
Contra-indication with the surgery or the anaesthesia.
Antecedent of prostate resection or adenomectomy.
Antecedent of inguinal hernia treatment.
Antecedent of deep venous thrombosis of the lower limbs or pulmonary embolism
Patient privatized of freedom.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Claude ABBOU, PU-PH
Phone
33 (0)1.49.81.25.51
Email
claude.abbou@hmn.aphp.fr
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Claude ABBOU, PU-PH
Organizational Affiliation
Assistance Publique - Hôpitaux de Paris
Official's Role
Principal Investigator
Facility Information:
Facility Name
Groupe Hospitalier Albert Chenevier Henri Mondor
City
Creteil
ZIP/Postal Code
94000
Country
France
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Claude ABBOU, PU-PH
Phone
+33 (0)1.49.81.25.51
Email
claude.abbou@hmn.aphp.fr
12. IPD Sharing Statement
Learn more about this trial
Multicentric Study Comparing Carcinological and Functional Results of Surgery
We'll reach out to this number within 24 hrs